Requires Authorization

Reactivity of FDA-approved anti-D reagents with partial D red blood cells

W.J. Judd

W.J. Judd

Department of Pathology, University of MichiganAnn Arbor, MI, United States
Search for this author on
Sciendo|Google Scholar
Judd, W.J.
, 
M. Moulds

M. Moulds

Immunohematology Reference Laboratory ImmucorGammaHouston, TX, United States
Search for this author on
Sciendo|Google Scholar
Moulds, M.
 and 
G. Schlanser

G. Schlanser

Immunohematology Reference Laboratory ImmucorGammaHouston, TX, United States
Search for this author on
Sciendo|Google Scholar
Schlanser, G.
  
May 01, 2020
Reactivity of FDA-approved anti-D reagents with partial D red blood cells's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: May 01, 2020
Page range: 146 - 148
DOI: https://doi.org/10.21307/immunohematology-2019-409
Keywords
© 2005 W.J. Judd, et al., published by Sciendo
Judd, W.J.
Department of Pathology, University of MichiganAnn Arbor, MI, United States
Moulds, M.
Immunohematology Reference Laboratory ImmucorGammaHouston, TX, United States
Schlanser, G.
Immunohematology Reference Laboratory ImmucorGammaHouston, TX, United States
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Laboratory Medicine
Journal RSS Feed